Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
As per available reports about Hepatitis C, OMICS International has 94 Open Access Articles, 153 Conference, 5 journals, 64 National symposiums, are being published and organized on Hepatitis C.
Hepatitis C is an infectious disease affecting primarily the liver, caused by the hepatitis C virus (HCV). HCV is spread primarily by blood-to-blood contact associated with intravenous drug use, poorly sterilized medical equipment, and transfusions. The infection is often asymptomatic, but chronic infection can lead to scarring of the liver and ultimately to cirrhosis, which is generally apparent after many years. In some cases, those with cirrhosis will go on to develop liver failure, liver cancer, or life-threatening esophageal and gastric varies.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance :
In the United States, about 2% of people have hepatitis C, with the number of new cases per year stabilized at 17,000 since 2007.The number of deaths from hepatitis C has increased to 15,800 in 2008 and by 2007 had overtaken HIV/AIDS as a cause of death in the USA. This mortality rate is expected to increase, as those infected by transfusion before HCV testing become apparent. In Europe the percentage of people with chronic infections has been estimated to be between 0.13 and 3.26%.The hepatitis C viruses cannot be spread by holding hands, sharing eating utensils, kissing, hugging, coughing, sneezing, or breastfeeding. It is a perfect platform to discuss the current discoveries and developments in the field of Hepatitis Disease prevention/Control/Treatment.
Market Analysis:
A new report by vision gain predicts the overall world market for hepatitis C virus (HCV) treatments will reach $32bn in 2018. That revenue forecast and others appear in Hepatitis C Therapies: World Industry, R&D and Market Forecasts 2015-2025, published in December 2014. Vision gain is a business information publisher and consultancy in London, UK.
List of Best International Conferences:
3rd HIV/AIDS, STDs and STIs Conference
November 30-December 02, 2015 Atlanta, USA
Rare Diseases and Orphan Drugs Congress
May 12-13, 2016 Chicago, USA
4th Bacteriology and Infectious Diseases Congress
May 16-18, 2016 San Antonio, USA
2nd Retroviruses and Novel Drugs Conference
June 30-July 01, 2016 Cape Town, South Africa
2nd Infectious Diseases Conference
August 25-27, 2016 Philadelphia, USA
3rd Hepatitis and Liver Diseases Conference
October 17-19, 2016 Dubai, UAE
2nd Flu Conference
November 17-19, 2016 San Francisco, USA
6th Euro Virology Conference
March 10-12 Madrid, Spain
Conference on Bio threats & Biodefense
October 17-19, 2016 Dubai, UAE
5th Virology Conference
December7-9, 2016 Atlanta, USA
20th AIDS Conferences
August 25-27, 2016 Texas, USA
15th European AIDS Conference
August 25-27, 2016 Philadelphia, USA
Social Work and HIV/AIDS Conference
November 17-19, 2016 San Francisco, USA
Relevant Society and Associations:
1. Hepatitis C Trust
2. Hindu Council UK (HCUK)
3. Bedford Hospital NHS Trust
4. American Medical Systems UK Ltd
5. Pharmaceutical Services Negotiating Committee
6. PharMAG
7. Philip Morris Limited
8. Poole Hospital Foundation Trust
9. Portsmouth Hospitals NHS Trust
10. The Royal Free Hampstead NHS Trust
Companies:
1. Novartis
2. Gilead Sciences
3. Bristol-Myers Squibb
4. GlaxoSmithKline
5. Schering
6. Roche
7. Merck & Co
8. Janssen
9. Vertex
10. Three Rivers Pharma
This page will be updated regularly.
This page was last updated on November 5, 2024
